KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Medtronic (MDT) Cost of Revenue (2016 - 2026)

Medtronic (MDT) has disclosed Cost of Revenue for 13 consecutive years, with $3.3 billion as the latest value for Q1 2026.

  • Quarterly Cost of Revenue rose 17.34% to $3.3 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $12.5 billion through Jan 2026, up 8.15% year-over-year, with the annual reading at $11.6 billion for FY2025, 3.71% up from the prior year.
  • Cost of Revenue hit $3.3 billion in Q1 2026 for Medtronic, up from $3.1 billion in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $3.3 billion in Q1 2026 to a low of $2.5 billion in Q1 2022.
  • Historically, Cost of Revenue has averaged $2.8 billion across 5 years, with a median of $2.8 billion in 2025.
  • Biggest five-year swings in Cost of Revenue: fell 6.18% in 2022 and later increased 17.34% in 2026.
  • Year by year, Cost of Revenue stood at $2.5 billion in 2022, then increased by 8.92% to $2.8 billion in 2023, then increased by 6.7% to $2.9 billion in 2024, then rose by 3.9% to $3.1 billion in 2025, then grew by 6.53% to $3.3 billion in 2026.
  • Business Quant data shows Cost of Revenue for MDT at $3.3 billion in Q1 2026, $3.1 billion in Q4 2025, and $3.0 billion in Q3 2025.